 This study is designed to be an interventional, prospective, randomized, double-blinded case-control clinical trial. Procedures will be done in the Center for Liver Diseases, 9Th floor of Kaufmann medical building, UPMC, USA. This study will also be carried out in National Liver Institute, Egypt. 